Table 1.
Baseline characteristics of Framingham Osteoporosis Study women by hip fracture status over follow-up
| Characteristica | Fracture | No fracture |
|---|---|---|
| N | 99 | 1,879 |
| Original Cohort (%) | 74 | 25 |
| Age (years) | 76.4 (6.5) | 66.4 (10.2) |
| Height (in) | 61.5 (2.6 ) | 62.8 (2.6) |
| Weight (lbs) | 136 (28) | 152 (31) |
| History of hip fracture (%) | 7 | 2 |
| Current smokers (%) | 12 | 12 |
| Physical Activity (PASE)b | 95 (46) | 124 (68) |
| Current osteoporosis medication use (%) | 3 | 3 |
| Femoral neck BMD (g/cm2)c | 0.66 (0.11) | 0.82 (0.14) |
| Current estrogen therapy use (%) | 7 | 25 |
| Total body percent fat mass (%)d | 37 | 41 |
| Leg lean mass (kg) | 11.3 (1.7) | 11.4 (1.6) |
| Total body lean mass (kg)d | 35.3 (4.3) | 35.9 (4.1) |
| Median follow-up (yrs) | 6.6 | 8.3 |
a
Mean ± standard deviation, unless otherwise noted.
b
N=166 (8%) missing
c
N=48 (2%) missing
d
N=166 (8%) missing